Stem Cell and Conditioned Medium for Cerebral Palsy
Launched by PT. PRODIA STEM CELL INDONESIA · Mar 17, 2020
Trial Information
Current as of July 01, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed as Cerebral palsy with total body involvement type
- • Age between 6 month - 3 years old
- • Parents requesting for cell therapy
- • The parents give sign in informed consent form do to examination, therapy, blood sampling collection and observation for their child
- Exclusion Criteria:
- • Head circumference less than -3 SD (more than 3 cm) Nellhaus standard
- • Have diagnosed meningitis and encephalitis
- • Have diagnosed congenital infection i.e. toxoplasmosis, rubella congenital, cytomegalovirus
- • Have diagnosed metabolic disorder, chromosome disorder, congenital malformation or neuroregeneratif disease
- • Progressive disorder
- • Regressive development disorder
- • Severe anatomical abnormalities in Brain MRI
About Pt. Prodia Stem Cell Indonesia
PT Prodia Stem Cell Indonesia is a leading biotechnology company dedicated to advancing regenerative medicine through innovative stem cell research and therapy. With a strong commitment to scientific excellence and patient care, the company focuses on developing cutting-edge treatments aimed at various medical conditions, while adhering to rigorous regulatory standards. As a sponsor of clinical trials, PT Prodia Stem Cell Indonesia collaborates with renowned research institutions and healthcare professionals to ensure the safety and efficacy of its therapies, ultimately striving to improve patient outcomes and contribute to the global advancement of stem cell medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jakarta, , Indonesia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials